Skip to content

ImmunityBio

US · IBRX #1397 by market cap Listed 1970
6.02 -0.55 -8.37%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:59

About ImmunityBio

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Founded
2014
CEO
Mr. Richard Adcock
Employees
691
Headquarters
San Diego, California, United States of America
Fiscal year end
12-31
Website
immunitybio.com

Company profile

Exchange
US
Symbol
IBRX
Market-cap rank
#1397
Listing date
1970-01-01
Market cap
6.40B
Float cap
2.47B
Shares out
1.06B
Float shares
410.68M

Sectors & themes

Biotechnology Top Gainers Yesterday Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:59:40 · For reference only, not investment advice and not tailored to your situation.

ImmunityBio discussion 0 comments

Add a comment